Role of extracellular vesicles in cell-cell communication and inflammation following exposure to pulmonary toxicants
•Extracellar vesicles are released following exposure to pulmonary toxicants.•Extracellular vesicles include exosomes, microvesicles and apoptotic bodies.•Extracellular vesicles contribute to cell cell communication and inflammation.•Extracellular vesicles contain cargo that mediate biological effec...
Gespeichert in:
Veröffentlicht in: | Cytokine & growth factor reviews 2020-02, Vol.51, p.12-18 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Extracellar vesicles are released following exposure to pulmonary toxicants.•Extracellular vesicles include exosomes, microvesicles and apoptotic bodies.•Extracellular vesicles contribute to cell cell communication and inflammation.•Extracellular vesicles contain cargo that mediate biological effects.
Extracellular vesicles (EVs) have emerged as key regulators of cell-cell communication during inflammatory responses to lung injury induced by diverse pulmonary toxicants including cigarette smoke, air pollutants, hyperoxia, acids, and endotoxin. Many lung cell types, including epithelial cells and endothelial cells, as well as infiltrating macrophages generate EVs. EVs appear to function by transporting cargo to recipient cells that, in most instances, promote their inflammatory activity. Biologically active cargo transported by EVs include miRNAs, cytokines/chemokines, damage-associated molecular patterns (DAMPs), tissue factor (TF)s, and caspases. Findings that EVs are taken up by target cells such as macrophages, and that this leads to increased proinflammatory functioning provide support for their role in the development of pathologies associated with toxicant exposure. Understanding the nature of EVs responding to toxic exposures and their cargo may lead to the development of novel therapeutic approaches to mitigating lung injury. |
---|---|
ISSN: | 1359-6101 1879-0305 |
DOI: | 10.1016/j.cytogfr.2019.12.001 |